Healthcare Scan

Scan

Healthcare Scan

Scan symbols 13
AMGNBIIBGILDISRGJNJLLYMDTMRNASYKTMOUNHVEEVVRTX
Watchlists 1
@healthcare-scan
raw scan snapshot — prices as of scan date, not live 20 rows · screens, not recommendations superseded by2026-04-26-healthcare-scanported fromresearch/classic/scans/_archive/2026-03-13-healthcare-scan.mdscan slughealthcare-scansource typescan-archive

Healthcare in broad selloff: SYK RSI 26.5, MDT RSI 22.3, TMO RSI 24.4 — medtech/tools capitulating. UNH continuing structural decline (-41% 1Y, death cross). JNJ and GILD holding as safe havens. MRNA surging +19.6% 30D. VRTX the strongest name at RSI 54.0 above SMA.

Quick Snapshot

Signal Reading
Overall 🔴 WEAK — Medtech (SYK, MDT, ISRG) and life sciences tools (TMO, VEEV) in deep drawdowns. Managed care (UNH) in structural decline. Large-cap pharma (JNJ, GILD, AMGN, VRTX) holding but fading. MRNA the sole bright spot.
Leaders MRNA (+19.6% 30D, RSI 55.5), JNJ (+2.5% 7D, +13.4% 3M), VRTX (+4.4% 30D, RSI 54.0)
Laggards MDT (RSI 22.3), TMO (RSI 24.4), SYK (RSI 26.5), UNH (-41.0% 1Y, death cross)

Price Table

Stock Price RSI SMA20 vs SMA 7D% 30D% Signal
SYK $336.71 26.5 $371.09 -9.3% -6.6% -8.8% 🔴 Medtech capitulation, death cross
ISRG $472.16 34.7 $494.58 -4.5% -1.0% -4.3% 🟡 Approaching oversold
MDT $87.13 22.3 $94.73 -8.0% -3.3% -9.6% 🔴 Capitulation
LLY $985.28 42.6 $1,015.39 -3.0% +0.1% -4.9% 🟡 Below SMA
GILD $144.99 49.0 $148.47 -2.3% +0.7% -6.6% 🟡 Neutral, strong-up
AMGN $366.21 47.7 $376.49 -2.7% +0.2% -1.9% 🟡 Neutral
BIIB $186.62 48.6 $190.83 -2.2% +0.6% -4.5% 🟡 Neutral
JNJ $241.55 54.0 $243.81 -0.9% +2.5% -0.2% 🟢 Safe haven, +27% vs SMA200
UNH $279.05 41.5 $285.14 -2.1% -1.3% -1.1% 🔴 Death cross, -41% 1Y
VEEV $187.09 46.3 $182.66 +2.4% -2.9% +8.8% 🟡 -39% from high, death cross
TMO $464.38 24.4 $506.46 -8.3% -6.0% -7.4% 🔴 Tools capitulation
VRTX $485.55 54.0 $478.62 +1.4% +5.2% +4.4% 🟢 Best in class
MRNA $52.56 55.5 $51.46 +2.1% +3.6% +19.6% 🟢 mRNA surge

Action Matrix

Action Stocks Why
✅ STRONG BUY MDT, TMO, SYK RSI 22-27, capitulation. Quality healthcare at steep discounts.
🔒 HOLD JNJ, VRTX, GILD, MRNA Above or near SMAs, defensive winners.
📈 ACCUMULATE LLY, AMGN, ISRG Below SMAs, pharma/medtech leaders. DCA.
⚠️ AVOID UNH -41% 1Y, structural decline. Managed care under political pressure.

What Changed

Bottom line: Healthcare is experiencing a medtech/tools capitulation (MDT, SYK, TMO all RSI < 27) while pharma and biotech hold better. UNH's continued decline (-41% 1Y) is a structural story. MRNA and VRTX are the sector winners.

The Gold

Key Discoveries:

  • MDT RSI 22.3 is the deepest oversold of any stock in the healthcare universe
  • TMO/DHR/SYK all RSI < 27 — life sciences/medtech capitulation is a sector-wide phenomenon
  • JNJ +52.5% 1Y vs UNH -41.0% 1Y — massive divergence within healthcare

Mistakes to Avoid:

  • Don't average down on UNH — structural managed care headwinds
  • Don't assume MDT/TMO capitulation = immediate bounce — verify earnings

Open Questions:

  • Is the medtech selloff driven by hospital spending cuts, tariffs on medical devices, or something else?
  • Is UNH's decline a managed care sector issue or company-specific?
10 events
DateTypeEvent
Mar 20 ScanHealthcare Scan Mar 24 ScanHealthcare Scan Mar 26 ScanHealthcare Scan Mar 31 ScanHealthcare Scan Apr 3 ScanHealthcare Scan Apr 10 ScanHealthcare Scan Apr 13 Scan2 — HEALTHCARE SCAN Mar 13 ScanBiotech Scan Mar 12 ScanBiotech Scan Mar 11 ScanBiotech Scan

No direct external sources are attached to this read.